Seattle has established itself as a leading hub at the intersection of biotech and AI, with growing investment and institutional support.
A recent Seattle Children’s panel addressed AI and drug development, highlighting the region’s world-class research institutions, deep technical expertise in both biology and computing, and collaborative culture that brings together academia, healthcare, and industry. “Seattle is the best place in the world to build an AI life sciences company,” said Hetu Kamisetty, CEO of Xaira.
As the city strives for the No. 1 spot in this rapidly evolving field, fresh innovation and investment continue to build Seattle’s influence at the intersection of AI and life sciences.